Showing results (91-100 of 412) with videos related to
Sort By:
Pageof 42
Pathology Research International|December 15, 2010
Immunophenotypical Switch versus Tumor Heterogeneity in a Patient with HIV-Associated Diffuse Large B-Cell LymphomaJorge J Castillo, Tina Rizack, Diana TreabaMediterranean Journal of Hematology and Infectious Diseases|July 10, 2024
Waldenström Macroglobulinemia - A State-of-the-Art Review: Part 1: Epidemiology, Pathogenesis, Clinicopathologic Characteristics, Differential Diagnosis, Risk Stratification, and Clinical ProblemsMichele Bibas, Shayna Sarosiek, Jorge J CastilloBritish Journal of Haematology|December 22, 2015
Central nervous system involvement by Waldenström macroglobulinaemia (Bing-Neel syndrome): a multi-institutional retrospective studyJorge J Castillo, Shirley D'Sa, Michael P Lunn, et al.Blood|February 26, 2017
Acquired mutations associated with ibrutinib resistance in Waldenström macroglobulinemiaLian Xu, Nicholas Tsakmaklis, Guang Yang, et al.Seminars in Hematology|May 12, 2023
Report of consensus Panel 4 from the 11th International Workshop on Waldenstrom's macroglobulinemia on diagnostic and response criteriaSteven P Treon, Alessandra Tedeschi, Jesus San-Miguel, et al.Hemasphere|July 11, 2020
Response and Survival Outcomes to Ibrutinib Monotherapy for Patients With Waldenström Macroglobulinemia on and off Clinical TrialsJorge J Castillo, Joshua N Gustine, Kirsten Meid, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 26, 2018
Ibrutinib Monotherapy in Symptomatic, Treatment-Naïve Patients With Waldenström MacroglobulinemiaSteven P Treon, Joshua Gustine, Kirsten Meid, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2015
Treatment selection and outcomes in early-stage classical Hodgkin lymphoma: analysis of the National Cancer Data BaseAdam J Olszewski, Rajesh Shrestha, Jorge J CastilloLeukemia Research|August 13, 2013
Multiple myeloma-induced hyperammonemic encephalopathy: an entity associated with high in-patient mortalityAnthony Pham, John L Reagan, Jorge J CastilloExpert Opinion on Investigational Drugs|November 25, 2011
CAL-101: a phosphatidylinositol-3-kinase p110-delta inhibitor for the treatment of lymphoid malignanciesJorge J Castillo, Michael Furman, Eric S WinerPageof 42